Relationship between Serum Metabolites and Oxidative Stress, Inflammation, and Gut Microbiota

Dear Colleagues,

Evidence shows that serum/circulating metabolites play a critical role in preventing, controlling, and treating chronic non-communicable diseases such as CVD and cancers. However, limited studies have been carried out on the relationship between serum dietary metabolites, focusing on the causative mechanisms of these diseases, associated with inflammation, oxidative stress, and gut microbiota. Investigating the circulating metabolic intermediates that may predict the risk of disease will help us to better understand the development of disease and develop methods to control or treat them. Additionally, suggesting a molecular basis for chronic non-communicable diseases based on clinical findings (e.g., serum/blood) is one of the areas that needs to be expanded, and the subsequent results will be helpful in better understanding the bio-development of diseases and the creation of therapeutic hypotheses. This Special Issue aims to publish quality articles examining between serum dietary metabolites and oxidative stress, inflammation, and gut microbiota. Contributions from every corner of biomedicine, including food chemistry, biochemistry, molecular biology, anatomy, physiology, pathology, microbiology, cell biology, toxicology, pharmacology, epidemiology, virology, bacteriology, immunology, genetics, embryology, etc., are welcome. However, reports must be based on serum/blood/circulating investigations, and be chemically well-defined. Outstanding cellular or animal models may be considered. Even if not associated with serum metabolites, gut microbiota results are welcome.

Dr. Farhad Vahid
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomedicines is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.